Amwill Health Care: New Import License for Hair Colour Products
REGULATORY
▲ Positive Development
LOW RISK
📅 Filed on BSE: 10 Oct 2026, 01:14 PM IST · BSE ID: 8087d2ca-d816-4334-8223-57d965564960
View Original BSE Filing (PDF)
💡
In Simple Terms
The company obtained government permission to import and sell a new hair color product in India.
🤖 AI Summary
- Amwill Health Care received import license for FoliColor- Oxidative hair colour.
- License granted by Central Drugs Standard Control Organization (CDSCO).
- Approval is for five years, valid from October 8, 2026, to October 7, 2031.
- This enables import and commercial sale of the product in India.
🔢 Key Numbers — exact figures from BSE filing, not rounded
License Validity Start Date
08-Oct-2026
License Validity End Date
07-Oct-2031
Registration Certificate Number
RC/COS-007631
🏢 How This Affects the Company
This approval enables Amwill Health Care to commence the import and commercial sale of FoliColor- Oxidative hair colour products in India. The company anticipates this will expand its product portfolio and contribute to revenue growth.
No immediate financial figures are provided, but the license is expected to contribute to future revenue generation.
The company can now initiate import logistics and sales operations for the approved hair colour product.
No new risks are explicitly detailed in the filing, but successful import and sales execution will be critical.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders.
👤
Who Is Affected
All shareholders are affected by management's initiative to expand the company's product offerings and revenue streams.
🔍
Management Signal
Management is actively pursuing product diversification and market access for new offerings.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Launch date of FoliColor- Oxidative hair colour in India.
Subsequent filings on actual import volumes and sales figures.
Future financial results reporting revenue contribution from new product.
LOW RISK
The filing concerns a routine regulatory approval for import, not a high-risk event.
💡 Investor Takeaway
Amwill Health Care secured a five-year import license from CDSCO for FoliColor- Oxidative hair colour, allowing commercial sales in India, which is expected to expand product portfolio and revenue.
⚖️ Strengths & Concerns
✅ Positives
- Secured a five-year import license for a new cosmetic product from CDSCO.
- Company expects to expand product portfolio and generate new revenue streams.
❓ Frequently Asked Questions
What approval did Amwill Health Care Ltd. receive?
Amwill Health Care received an import registration certificate from CDSCO to import FoliColor- Oxidative hair colour products.
Who granted the import license to Amwill Health Care?
The Central Drugs Standard Control Organization (CDSCO) granted the import license.
What is the validity period of the import license?
The license is valid from October 8, 2026, up to October 7, 2031.
What product can Amwill Health Care import with this license?
Amwill Health Care can import 'FoliColor- Oxidative hair colour' products, specifically the Black variant.
What is the registration certificate number for this import license?
The registration certificate number is RC/COS-007631.
Questions based on this BSE filing only. For information purposes.